Technical Analysis for MLND - Millendo Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 16.32 -0.55% -0.09
MLND closed down 0.55 percent on Monday, May 20, 2019, on 27 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical MLND trend table...

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
20 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
20 DMA Support Bullish -0.55%
Bollinger Band Squeeze Range Contraction -0.55%

Older signals for MLND ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Millendo Therapeutics is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases where current therapies do not exist or are insufficient. The Company’s objective is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of endocrine diseases where there is a significant unmet medical need. The Company is currently advancing livoletide for the treatment of Prader-Willi syndrome and nevanimibe for the treatment of classic congenital adrenal hyperplasia and endogenous Cushing’s syndrome.
Organ Systems Endocrine System Late Stage Biopharmaceutical Cushing's Syndrome Adrenal Gland Disorders Endocrine Diseases Prader Willi Syndrome
Is MLND a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.34
52 Week Low 6.77
Average Volume 40,063
200-Day Moving Average 11.9924
50-Day Moving Average 15.4504
20-Day Moving Average 16.2155
10-Day Moving Average 16.405
Average True Range 0.8505
ADX 17.94
+DI 14.0551
-DI 19.8389
Chandelier Exit (Long, 3 ATRs ) 14.3785
Chandelier Exit (Short, 3 ATRs ) 17.1515
Upper Bollinger Band 16.8155
Lower Bollinger Band 15.6155
Percent B (%b) 0.59
BandWidth 7.400327
MACD Line 0.3087
MACD Signal Line 0.3591
MACD Histogram -0.0504
Fundamentals Value
Market Cap 582.44 Million
Num Shares 35.7 Million
EPS -2.11
Price-to-Earnings (P/E) Ratio -7.73
Price-to-Sales 116.65
Price-to-Book 0.67
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.79
Resistance 3 (R3) 16.75 16.55 16.71
Resistance 2 (R2) 16.55 16.43 16.57 16.68
Resistance 1 (R1) 16.44 16.36 16.50 16.48 16.66
Pivot Point 16.24 16.24 16.27 16.26 16.24
Support 1 (S1) 16.13 16.12 16.19 16.17 15.98
Support 2 (S2) 15.93 16.05 15.95 15.96
Support 3 (S3) 15.82 15.93 15.93
Support 4 (S4) 15.86